INS and obesity disorder: Probiotics have emerged as a safe and effective option for treating HFD-induced obesity in animals, with few adverse effects and good tolerance, making them ideal for long-term administration (Liu et al., 2017), and the combination of Lactobacillus and Bifidobacterium has been shown to significantly alter gut microbiota composition and improve insulin sensitivity in HFD mice.